SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-020178
Filing Date
2020-04-30
Accepted
2020-04-30 16:10:26
Documents
5
Period of Report
2020-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20200430.htm 8-K 55616
2 EX-10.1 acer-ex101_18.htm EX-10.1 377628
3 EX-10.2 acer-ex102_19.htm EX-10.2 188613
4 EX-99.1 acer-ex991_6.htm EX-99.1 13875
5 GRAPHIC go5inhc4lop4000001.jpg GRAPHIC 2729
  Complete submission text file 0001564590-20-020178.txt   641201
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 20835744
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences